Assignee

PASTEUR INSTITUT

FR794 patents

Top patents by PatentIndex Score

US6833252B1Dec 21, 2004

Nucleotide sequence encoding the enzyme I-SecI and the uses thereof

PASTEUR INSTITUT277 citations98

US6682907B1Jan 27, 2004

Use of triplex structure DNA in transferring nucleotide sequences

PASTEUR INSTITUT198 citations98

US4708818ANov 24, 1987

Human immunodeficiency viruses associated with Acquired Immune Deficiency Syndrome (AIDS), a diagnostic method for AIDS and pre-AIDS, and a kit therefor

PASTEUR INSTITUT166 citations98

US6294324B1Sep 25, 2001

Process for aligning, adhering and stretching nucleic acid strands on a support surface by passage through a meniscus

PASTEUR INSTITUT125 citations97

US5792632AAug 11, 1998

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

PASTEUR INSTITUT89 citations97

US4839288AJun 13, 1989

Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes

PASTEUR INSTITUT97 citations97

US7309605B1Dec 18, 2007

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

PASTEUR INSTITUT44 citations96

US6979535B2Dec 27, 2005

Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays

PASTEUR INSTITUT44 citations96

US6822137B1Nov 23, 2004

Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof

PASTEUR INSTITUT42 citations96

US6544728B1Apr 8, 2003

Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2

PASTEUR INSTITUT50 citations96

US6528313B1Mar 4, 2003

Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made

PASTEUR INSTITUT139 citations96

US6528314B1Mar 4, 2003

Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made

PASTEUR INSTITUT121 citations96

US6395959B1May 28, 2002

Nucleotide sequence encoding the enzyme I SceI and the use thereof

PASTEUR INSTITUT45 citations96

US6265153B1Jul 24, 2001

Process for aligning macromolecules by passage of a meniscus and applications

PASTEUR INSTITUT46 citations96

US6261762B1Jul 17, 2001

Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits

PASTEUR INSTITUT56 citations96

US6011146AJan 4, 2000

Altered major histocompatibility complex (MHC) determinant and methods of using the determinant

PASTEUR INSTITUT148 citations96

US5976551ANov 2, 1999

Altered major histocompatibility complex (MHC) determinant and method of using the determinant

PASTEUR INSTITUT191 citations96

US5948678ASep 7, 1999

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

PASTEUR INSTITUT55 citations96

US5906817AMay 25, 1999

Biocompatible implant for the expression and in vivo secretion of a therapeutic substance

PASTEUR INSTITUT171 citations96

US5866361AFeb 2, 1999

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

PASTEUR INSTITUT46 citations96

US5846724ADec 8, 1998

Highly specific surface for biological reactions having an exposed ethylenic double bond, process of using the surface, and method for assaying for a molecule using the surface

PASTEUR INSTITUT38 citations96

US5079342AJan 7, 1992

Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits

PASTEUR INSTITUT60 citations96

US5055391AOct 8, 1991

Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2)

PASTEUR INSTITUT48 citations96

US5051496ASep 24, 1991

Peptides related to human immunodeficiency virus II (HIV-2)

PASTEUR INSTITUT46 citations96

US4581333AApr 8, 1986

Method of detecting and characterizing a nucleic acid or reactant for the application of this method

PASTEUR INSTITUT402 citations96

US7087231B2Aug 8, 2006

Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes

PASTEUR INSTITUT36 citations95

US6686194B1Feb 3, 2004

Method and device for selecting accelerated proliferation of living cells in suspension

PASTEUR INSTITUT103 citations95

US6638768B1Oct 28, 2003

Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made

PASTEUR INSTITUT92 citations95

US6344319B1Feb 5, 2002

Method for diagnosis of genetic diseases by molecular combing and diagnosis box

PASTEUR INSTITUT64 citations95

US6242250B1Jun 5, 2001

Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions

PASTEUR INSTITUT27 citations95

US6194142B1Feb 27, 2001

Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses

PASTEUR INSTITUT34 citations95

US6107086AAug 22, 2000

Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions

PASTEUR INSTITUT31 citations95

US6103462AAug 15, 2000

Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance

PASTEUR INSTITUT56 citations95

US5958674ASep 28, 1999

Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections

PASTEUR INSTITUT42 citations95

US5876922AMar 2, 1999

Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections

PASTEUR INSTITUT60 citations95

US5876723AMar 2, 1999

Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition

PASTEUR INSTITUT33 citations95

US5824466AOct 20, 1998

Purified polypeptide of human papillomavirus type 49 (HPV49) type 50 (HVP50), and type 55 (HPV55)

PASTEUR INSTITUT29 citations95

US5786177AJul 28, 1998

Nucleotide sequences derived from the genome or retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses

PASTEUR INSTITUT39 citations95

US5712092AJan 27, 1998

Papillomavirus probe and process for in vitro diagnosis of papillomavirus infections

PASTEUR INSTITUT55 citations95

US5688637ANov 18, 1997

Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the disease due to these viruses

PASTEUR INSTITUT53 citations95

US5677126AOct 14, 1997

Highly specific surface for biological reactions having an exposed ethylenic double bond, process of using the surface, and method for assaying for a molecule using the surface

PASTEUR INSTITUT29 citations95

US5648459AJul 15, 1997

Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions

PASTEUR INSTITUT34 citations95

US5591574AJan 7, 1997

Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50

PASTEUR INSTITUT32 citations95

US5554538ASep 10, 1996

DNA sequences derived from papillomavirus HPV-33 genome

PASTEUR INSTITUT42 citations95

US5534439AJul 9, 1996

Isolated DNA of human papillomavirus type 55 (HPV55)

PASTEUR INSTITUT29 citations95

US5503829AApr 2, 1996

Recombinant mutants for inducing specific immune responses

PASTEUR INSTITUT58 citations95

US5376530ADec 27, 1994

Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor

PASTEUR INSTITUT119 citations95

Showing the top 50 of 794 patents by PatentIndex Score.

PASTEUR INSTITUT

Top patents by PatentIndex Score

Nucleotide sequence encoding the enzyme I-SecI and the uses thereof

Use of triplex structure DNA in transferring nucleotide sequences

Human immunodeficiency viruses associated with Acquired Immune Deficiency Syndrome (AIDS), a diagnostic method for AIDS and pre-AIDS, and a kit therefor

Processing for attaching an end of a nucleic acid to a surface by utilizing pH

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

Process for aligning macromolecules on a surface by passage through a meniscus

Process for aligning, adhering and stretching nucleic acid strands on a support surface by passage through a meniscus

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays

Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof

Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2

Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made

Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made

Nucleotide sequence encoding the enzyme I SceI and the use thereof

Process for aligning macromolecules by passage of a meniscus and applications

Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits

Altered major histocompatibility complex (MHC) determinant and methods of using the determinant

Altered major histocompatibility complex (MHC) determinant and method of using the determinant

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

Biocompatible implant for the expression and in vivo secretion of a therapeutic substance

Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

Highly specific surface for biological reactions having an exposed ethylenic double bond, process of using the surface, and method for assaying for a molecule using the surface

Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits

Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2)

Peptides related to human immunodeficiency virus II (HIV-2)

Method of detecting and characterizing a nucleic acid or reactant for the application of this method

Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes

Method and device for selecting accelerated proliferation of living cells in suspension

Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made

Method for diagnosis of genetic diseases by molecular combing and diagnosis box

Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions

Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses

Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions

Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance

Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections

Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections

Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition

Purified polypeptide of human papillomavirus type 49 (HPV49) type 50 (HVP50), and type 55 (HPV55)

Nucleotide sequences derived from the genome or retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses

Papillomavirus probe and process for in vitro diagnosis of papillomavirus infections

Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the disease due to these viruses

Highly specific surface for biological reactions having an exposed ethylenic double bond, process of using the surface, and method for assaying for a molecule using the surface

Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions

Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50

DNA sequences derived from papillomavirus HPV-33 genome

Isolated DNA of human papillomavirus type 55 (HPV55)

Recombinant mutants for inducing specific immune responses

Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor